List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 11 studies with search of: abiraterone
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting A QT/QTc and Multi-Dose Pharmacokinetic (PK) Study of Abiraterone Acetate
Condition: Metastatic Castration-Resistant Prostate Cancer
Intervention: Drug: abiraterone acetate plus prednisone
2 Recruiting Continuous Oral Abiraterone in Castration Resistant Prostate Cancer
Condition: Castration-Resistant Prostate Cancer
Interventions: Drug: Abiraterone Acetate;   Drug: Prednisone
3 Active, not recruiting Study of Abiraterone Acetate in Patients With Prostate Cancer
Condition: Hormon Refractory Prostate Cancer
Intervention: Drug: Abiraterone acetate
4 Recruiting Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: abiraterone acetate;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies
5 Recruiting Neoadjuvant Abiraterone Acetate Plus Leuprolide Acetate in Men With Localized High Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: abiraterone acetate plus leuprolide acetate plus prednisone;   Drug: leuprolide acetate
6 Recruiting Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: abiraterone acetate plus prednisone/prednisolone;   Drug: placebo plus prednisone/prednisolone
7 Active, not recruiting Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Condition: Metastatic Castration-Resistant Prostate Cancer
Interventions: Drug: placebo plus prednisone/prednisolone;   Drug: abiraterone acetate plus prednisone/prednisolone
8 Active, not recruiting Phase I/II Study of Abiraterone Acetate in Hormone Refractory Prostate Cancer
Condition: Hormone Refractory Prostate Cancer
Intervention: Drug: abiraterone acetate (CB7630)
9 Active, not recruiting Clinical Study of Abiraterone Acetate and Prednisone in Patients With Advanced Prostate Cancer Who Have Failed Androgen Deprivation and Docetaxel-Based Chemotherapy
Condition: Hormone Refractory Prostate Cancer
Interventions: Drug: Abiraterone acetate (CB7630);   Drug: Prednisone/prednisolone
10 Active, not recruiting A Phase II Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Failed Taxane-Based Chemotherapy
Condition: Prostate Cancer
Intervention: Drug: Abiraterone Acetate
11 Active, not recruiting Pharmacokinetic Study of Abiraterone Acetate Tablets and Capsules Followed by Safety and Efficacy Evaluation of Continuous Tablet Dosing
Condition: Prostate Cancer
Intervention: Drug: abiraterone acetate plus prednisone/prednisolone

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services